| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.21M | 85.80M | 109.22M | 147.99M | 143.24M | 147.70M |
| Gross Profit | 16.97M | 13.55M | 18.72M | 25.68M | 26.11M | 29.77M |
| EBITDA | -3.09M | -1.53M | 2.57M | 19.74M | 7.50M | 5.00M |
| Net Income | -3.97M | -4.42M | -1.07M | 14.41M | 2.35M | 1.95M |
Balance Sheet | ||||||
| Total Assets | 94.49M | 115.04M | 95.97M | 117.54M | 108.82M | 135.18M |
| Cash, Cash Equivalents and Short-Term Investments | 25.69M | 26.55M | 27.40M | 27.26M | 28.60M | 45.77M |
| Total Debt | 6.71M | 8.36M | 9.84M | 16.23M | 13.48M | 22.78M |
| Total Liabilities | 32.77M | 40.67M | 42.55M | 58.94M | 58.12M | 67.02M |
| Stockholders Equity | 42.89M | 44.90M | 54.66M | 59.50M | 50.69M | 68.14M |
Cash Flow | ||||||
| Free Cash Flow | 8.94M | 4.71M | 9.54M | 4.10M | 2.50M | 4.21M |
| Operating Cash Flow | 9.30M | 5.34M | 10.95M | 4.96M | 3.78M | 5.97M |
| Investing Cash Flow | -509.98K | -433.00K | 526.00K | -1.16M | -2.60M | -1.60M |
| Financing Cash Flow | -3.76M | -5.54M | -10.54M | -1.42M | -6.93M | -871.71K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | S$56.91M | 10.16 | 5.07% | 4.10% | -6.98% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | S$237.33M | 50.00 | 40.64% | ― | 31.67% | 250.00% | |
55 Neutral | S$28.41M | -7.31 | -6.67% | 9.81% | -13.03% | 0.55% | |
53 Neutral | S$52.11M | -9.34 | -13.95% | ― | -11.99% | -2666.67% | |
46 Neutral | S$27.63M | -4.75 | -8.14% | ― | -11.04% | -360.44% |
CDW Holding Limited has announced a change in the legal representative for its Japanese subsidiaries, GSP Enterprise Inc. and CDW Life Science Limited. With effect from 1 January 2026, Mr. NAKAHARA Satoshi replaces Mr. IMAI Junya as legal representative of both entities, signaling an adjustment in local corporate governance and management representation for the group’s operations in Japan.
The most recent analyst rating on (SG:BXE) stock is a Hold with a S$0.14 price target. To see the full list of analyst forecasts on CDW Holding stock, see the SG:BXE Stock Forecast page.
CDW Holding Limited has announced a significant technological breakthrough with the development of a new additive for anti-fouling ship hull bottom paint, which has shown favorable results in static immersion tests in seawater. This innovation aligns with global efforts to reduce carbon emissions in the shipping industry and highlights CDW’s commitment to sustainability. The company is seeking strategic partnerships to further develop this next-generation graphene-based coating additive, which could enhance its market position and offer substantial benefits to stakeholders by addressing persistent marine challenges.